Pharmacokinetic Properties of Lorcaserin in Subjects With Hepatic Impairment

Clinical trial NCT00828932 · COMPLETED

Trial details

NCT number: NCT00828932
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2008-08-01
Primary completion: 2008-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.